HP2 Pep-LNP
Cat. No.: TDLD-0126-LD103
HP2 Pep-LNP
HP2 Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) engineered for targeted delivery applications, leveraging the HP2 peptide to enhance stability and enable specific targeting capabilities. It supports efficient delivery of therapeutic agents, facilitating research in targeted drug delivery systems. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear All
For Research Use Only. Not for Diagnostic or Treatment Applications.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | HP2 Peptide |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Related Products
Pep-1 Pep-LNP (TDLD-0126-LD125)
Apamin Pep-LNP (TDLD-0126-LD61)
NYZL1 Pep-LNP (TDLD-0825-LD96)
Claudin 18.2 CAR mRNA-LNP (TDLD-0825-LD46)
Targeted CD117 Ab-LNP (TDLD-0825-LD69)
FSHB Pep-LNP (TDLD-0825-LD95)
CD7 CAR mRNA-LNP (TDLD-0825-LD30)
GPRC5D CAR mRNA-LNP (TDLD-0825-LD45)
Online Inquiry
